Addressing patient concerns about intravenous iron therapy.

Nephrol Nurs J

Dialysis Services, Transplantation and Advanced Organ Support, Hartford Hospital, Hartford, CT, USA.

Published: April 2003

Hemodialysis patients may not fully understand the relationship between anemia and kidney disease and the role of intravenous (i.v.) iron therapy in anemia management. To address this, nephrology nurses have willingly undertaken the role of patient educator in addition to technical expert. This responsibility is challenging because nurses need to understand the rationale for i.v. iron therapy and the efficacy and safety characteristics of the available i.v. iron therapies, which include iron dextran, iron sucrose, and sodium ferric gluconate. Nurses must then be able to effectively communicate this knowledge to their patients in an understandable fashion. This manuscript offers suggestions to nurses for approaches to address patient concerns about i.v. iron therapies, the latest information regarding the efficacy and safety of i.v. iron treatments, and strategies to communicate this information to patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

iron therapy
12
patient concerns
8
iron
8
intravenous iron
8
efficacy safety
8
iron therapies
8
addressing patient
4
concerns intravenous
4
therapy hemodialysis
4
hemodialysis patients
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!